Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
NCT07392957
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
CTX-009
DRUG:
CTX-471
Sponsor
Washington University School of Medicine
Collaborators
[object Object]